GlassScriptPhysician profile
Alexa B Kahn
NPI 1952964884
$5,214.83
in general payments reported to CMS, 2019-2025
29 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $492 · 2023: $2,177 · 2024: $1,401 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,633 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,632.61 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $646.97 | 2022-2025 | Lifevest |
| Inari Medical, INC. | $600.09 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Alnylam Pharmaceuticals INC. | $519.75 | 2022-2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $499.41 | 2023-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $480.58 | 2023-2025 | Farxiga |
| Shockwave Medical, INC | $476.49 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Irhythm Technologies, INC. | $311.31 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Abiomed | $279.43 | 2022-2025 | Impella |
| Pfizer INC. | $189.94 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $189.18 | 2023 | Verquvo |
| Amgen INC. | $181.11 | 2023-2024 | Repatha |
| Daiichi Sankyo INC. | $180.80 | 2022-2024 | Injectafer |
| Cook Medical LLC | $114.12 | 2024 | Zilver Ptx |
| Janssen Pharmaceuticals, INC | $90.06 | 2023-2024 | Xarelto |
| Aurinia Pharma U.S., INC. | $82.47 | 2024 | Lupkynis |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $48.85 | 2023 | Opsumit, Uptravi |
| Abbott Laboratories | $45.48 | 2024-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Biotronik INC. | $39.24 | 2024 | Pamira |
| Bridgebio Pharma, INC. | $29.43 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $26.80 | 2022 | |
| Bardy Diagnostics, INC. | $26.32 | 2022 | |
| Kestra Medical Technology Services, INC. | $23.47 | 2024 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $23.40 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $22.17 | 2023 | |
| Philips North America LLC | $21.56 | 2023 | |
| Chiesi USA, INC. | $20.99 | 2024 | Kengreal |
| W. L. Gore & Associates, INC. | $15.62 | 2024 | Gore Cardioform Septal Occluder |
| Boston Scientific Corporation | $14.92 | 2023 | |
| Medtronic, INC. | $14.87 | 2025 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Kahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.